ECEC(SZ:002140)2023-04-28 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥869,287,711.49, representing a 17.86% increase compared to ¥737,548,930.55 in the same period last year[2] - Net profit attributable to shareholders for Q1 2023 was ¥71,650,773.81, a 7.10% increase from ¥66,899,044.57 year-on-year[2] - The total operating revenue for Q1 2023 was CNY 869.29 million, an increase of 17.9% compared to CNY 737.55 million in the same period last year[14] - The net profit for the first quarter of 2023 was CNY 71,480,979.99, an increase from CNY 69,158,358.57 in the same period last year, representing a growth of approximately 3.3%[15] - Operating profit for the first quarter was CNY 83,500,412.66, compared to CNY 79,958,917.74 in the previous year, indicating an increase of about 6.4%[15] - The company's total comprehensive income for the first quarter was CNY 71,480,979.99, up from CNY 69,158,358.57 in the previous year, reflecting an increase of about 3.3%[16] Cash Flow and Assets - The net cash flow from operating activities was -¥322,528,045.82, a decrease of 260.66% compared to ¥200,749,981.79 in the previous year[5] - The company's cash and cash equivalents decreased to CNY 2.76 billion from CNY 3.31 billion at the beginning of the year[11] - The total current assets as of March 31, 2023, amounted to CNY 8.38 billion, compared to CNY 8.27 billion at the beginning of the year, showing a slight increase[12] - The total liabilities as of March 31, 2023, were CNY 7.91 billion, compared to CNY 7.81 billion at the beginning of the year[13] - Total cash and cash equivalents at the end of the period were CNY 2,734,181,309.64, an increase from CNY 2,413,334,741.71 year-on-year[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 35,603[6] - The weighted average return on equity decreased to 1.92% from 2.53% in the previous year[2] Earnings Per Share - The basic earnings per share decreased by 18.48% to ¥0.1019, while diluted earnings per share decreased by 17.81% to ¥0.1015[2] - The company reported a basic earnings per share of CNY 0.1019, compared to CNY 0.1250 in the previous year, indicating a decrease of about 18.4%[16] Investment Activities - The company reported a significant decrease in investment cash flow, with a net outflow of -¥19,856,020.00, down 132.93% from the previous year[5] - The total investment activities resulted in a net cash outflow of CNY -198,560,227.69, compared to CNY -85,243,657.49 in the same period last year[19] Operating Costs - The total operating costs for Q1 2023 were CNY 803.69 million, up from CNY 743.96 million, reflecting a year-on-year increase of 8.0%[14] - The company incurred sales expenses of CNY 9,936,261.79, down from CNY 11,754,593.27 in the previous year, a decrease of approximately 15.5%[15] Research and Development - Research and development expenses amounted to CNY 20,422,622.04, slightly down from CNY 22,555,592.75 in the same quarter last year[15] Joint Ventures and Projects - The company is involved in a joint venture with Yulin Chemical, holding a 60% stake, to participate in the bankruptcy reorganization of Inner Mongolia Kanel, with an asset valuation of CNY 1.39 billion[8] - The expected cash payment for the reorganization is CNY 318.27 million, with the company responsible for CNY 190.96 million of that amount[8] - The company plans to complete the construction and production of a 300,000 tons/year ethylene glycol facility by the end of 2023[8] Accounts Receivable - Accounts receivable increased to CNY 890.99 million from CNY 723.68 million, representing a growth of 23.1%[12] Equity - The company's total equity as of March 31, 2023, was CNY 4.02 billion, up from CNY 3.94 billion at the beginning of the year[13]